- Home
- CVKD vs EMKR Comparison
CVKD vs EMKR Comparison
Compare CVKD & EMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- EMKR
- Stock Information
- Founded
- CVKD 2022
- EMKR 1984
- Country
- CVKD United States
- EMKR United States
- Employees
- CVKD N/A
- EMKR N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- EMKR Semiconductors
- Sector
- CVKD Health Care
- EMKR Technology
- Exchange
- CVKD Nasdaq
- EMKR Nasdaq
- Market Cap
- CVKD 17.1M
- EMKR 9.5M
- IPO Year
- CVKD 2023
- EMKR 1997
- Fundamental
- Price
- CVKD $15.24
- EMKR $2.33
- Analyst Decision
- CVKD Strong Buy
- EMKR Buy
- Analyst Count
- CVKD 2
- EMKR 2
- Target Price
- CVKD $52.50
- EMKR $3.00
- AVG Volume (30 Days)
- CVKD 59.6K
- EMKR 2.0M
- Earning Date
- CVKD 11-08-2024
- EMKR 12-10-2024
- Dividend Yield
- CVKD N/A
- EMKR N/A
- EPS Growth
- CVKD N/A
- EMKR N/A
- EPS
- CVKD N/A
- EMKR N/A
- Revenue
- CVKD N/A
- EMKR $90,961,000.00
- Revenue This Year
- CVKD N/A
- EMKR N/A
- Revenue Next Year
- CVKD N/A
- EMKR $7.07
- P/E Ratio
- CVKD N/A
- EMKR N/A
- Revenue Growth
- CVKD N/A
- EMKR 413.79
- 52 Week Low
- CVKD $5.40
- EMKR $0.78
- 52 Week High
- CVKD $32.55
- EMKR $7.20
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- EMKR 67.47
- Support Level
- CVKD $11.19
- EMKR $2.07
- Resistance Level
- CVKD $15.93
- EMKR $2.54
- Average True Range (ATR)
- CVKD 1.36
- EMKR 0.16
- MACD
- CVKD 0.23
- EMKR -0.02
- Stochastic Oscillator
- CVKD 61.01
- EMKR 55.32
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.